Literature DB >> 6334517

The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.

K Mertens, R M Bertina.   

Abstract

The role of the cofactors Ca2+ and phospholipid in the activation of human Factor X by Factor IXa was investigated. By use of a sensitive spectrophotometric Factor Xa assay, it was demonstrated that human Factor IXa can activate Factor X in the absence of cofactors. The presence of Ca2+ as the only cofactor resulted in a 7-fold stimulation of the Factor Xa formation. Kinetic analysis of the Ca2+-stimulated reaction showed that the apparent Km of Factor X was 4.6 microM, whereas the apparent Vmax. for Factor Xa formation was 0.0088 mol of Xa/min per mol of IXa. The presence of phospholipid as the only cofactor had no effect on the rate of Factor Xa formation. However, a several-hundred-fold stimulation was observed when Ca2+ and phospholipid were present in combination. The activation of Factor X in the presence of Ca2+ and phospholipid was found to be kinetically heterogeneous, involving both phospholipid-bound and free reactants. Quantitative data concerning the phospholipid binding of Factors IXa and X were used to study the relation between the rate of Factor Xa formation and the binding of enzyme and substrate to the phospholipid membrane. The results support the hypothesis that phospholipid-bound Factor X is the substrate in the phospholipid-stimulated reaction; however, phospholipid-bound and free Factor IXa seem to be equally efficient in catalysing the activation of phospholipid-bound Factor X.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334517      PMCID: PMC1144343          DOI: 10.1042/bj2230607

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

Review 1.  The role of serine proteases in the blood coagulation cascade.

Authors:  E W Davie; K Fujikawa; K Kurachi; W Kisiel
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1979

2.  Synthesis of intrinsic factor X activator. Inhibition of the function of formed activator by antibodies to factor VIII and to factor IX.

Authors:  B Osterud; S I Rapaport
Journal:  Biochemistry       Date:  1970-04-14       Impact factor: 3.162

3.  The interaction of Ca2+ with human Factor IX.

Authors:  G W Amphlett; W Kisiel; F J Castellino
Journal:  Arch Biochem Biophys       Date:  1981-05       Impact factor: 4.013

4.  The role of phospholipid and factor VIIIa in the activation of bovine factor X.

Authors:  G van Dieijen; G Tans; J Rosing; H C Hemker
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

5.  Reaction sequence of blood coagulation.

Authors:  H C Hemker; M J Kahn
Journal:  Nature       Date:  1967-09-09       Impact factor: 49.962

6.  Studies on the formation of the prothrombin-converting complex.

Authors:  F Jobin; M P Esnouf
Journal:  Biochem J       Date:  1967-03       Impact factor: 3.857

7.  The association of bovine prothrombin fragment 1 with phospholipid. Quantitative characterization of the Ca2+ ion-mediated binding of prothrombin fragment 1 to phospholipid vesicles and a molecular model for its association with phospholipids.

Authors:  F A Dombrose; S N Gitel; K Zawalich; C M Jackson
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

8.  "Clotspeed," a mathematical simulation of the functional properties of prothrombinase.

Authors:  M E Nesheim; R P Tracy; K G Mann
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

9.  Measurement of human factor IXa activity in an isolated factor X activation system.

Authors:  M J Griffith; H M Reisner; R L Lundblad; H R Roberts
Journal:  Thromb Res       Date:  1982-08-01       Impact factor: 3.944

10.  Pathways in the activation of human coagulation factor X.

Authors:  K Mertens; R M Bertina
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

View more
  10 in total

Review 1.  Microparticles in stored red blood cells: submicron clotting bombs?

Authors:  Olivier Rubin; David Crettaz; Jean-Daniel Tissot; Niels Lion
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

2.  Impact of microparticles derived from erythrocytes on fibrinolysis.

Authors:  Grigory Levin; Ekaterina Sukhareva; Athina Lavrentieva
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

3.  Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation.

Authors:  H J Brinkman; P Koster; K Mertens; J A van Mourik
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

4.  Surface-loop residue Lys316 in blood coagulation Factor IX is a major determinant for Factor X but not antithrombin recognition.

Authors:  J A Kolkman; K Mertens
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

5.  Heparin modulates the 99-loop of factor IXa: effects on reactivity with isolated Kunitz-type inhibitor domains.

Authors:  Pierre F Neuenschwander; Stephen R Williamson; Armen Nalian; Kimberly J Baker-Deadmond
Journal:  J Biol Chem       Date:  2006-06-09       Impact factor: 5.157

6.  An ordered sequential mechanism for Factor IX and Factor IXa binding to platelet receptors in the assembly of the Factor X-activating complex.

Authors:  Xia Yang; Peter N Walsh
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

7.  Binding of human blood-coagulation Factors IXa and X to phospholipid membranes.

Authors:  K Mertens; R Cupers; A Van Wijngaarden; R M Bertina
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

8.  The association of human coagulation factors VIII, IXa and X with phospholipid vesicles involves both electrostatic and hydrophobic interactions.

Authors:  J S Atkins; P R Ganz
Journal:  Mol Cell Biochem       Date:  1992-05-13       Impact factor: 3.396

9.  The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.

Authors:  V J Bom; R M Bertina
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

10.  Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.

Authors:  M J Donath; R T de Laaf; P T Biessels; P J Lenting; J W van de Loo; J A van Mourik; J Voorberg; K Mertens
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.